• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDCOMP MEDCOMP SPLIT CATH II; CATHETER, HEMODIALYSIS, IMPLANTED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDCOMP MEDCOMP SPLIT CATH II; CATHETER, HEMODIALYSIS, IMPLANTED Back to Search Results
Patient Problems Bacterial Infection (1735); Sepsis (2067); Fungal Infection (2419); Thrombosis/Thrombus (4440); Drug Resistant Bacterial Infection (4553)
Event Type  Injury  
Event Description
According to the literature, a retrospective cohort study between 2012 and 2018 was undertaken to determine the infection free survival rate of tunneled cuffed catheters (tcc), the incidence and causes of catheter failure, and the associated risk factors in children undergoing maintenance hemodialysis through tunneled catheters.Forty-five (45) tccs were inserted in patients between the ages of 5 and 16.Either a silicone mahurkar catheter in sizes 8, 10, or 12.5 fr was used or a competitor device.Nine deaths were reported where 3 died due to catheter related blood stream infection (crbsi) associated sepsis and 6 due to causes unrelated to the catheter.Serious complications included infection in 15 patients where the organism of infection was either gram negative bacilli, klebsiella, pseudomonas, mrsa, citrobacter, acinetobacter, or candida glabra.Infections were treated with either antibiotics or catheter removal.Thrombosis occurred in 13 patients.Thrombosis was treated with either urokinase locking solutions, recombinant-urokinase infusions, or catheter removal.Non-serious complications included 2 kinking and malposition of catheters which were either managed with wire manipulation or catheter removal and 3 catheters that were cracked were removed and replaced with another catheter.The authors do not provide information on which reported adverse events are related to mahurkar catheters or a competitor device.This report reflects information received by fda in the form of a notification per 803.22 (b)(2).Reference reports: mw5149530, mw5149531, mw5149533.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDCOMP SPLIT CATH II
Type of Device
CATHETER, HEMODIALYSIS, IMPLANTED
Manufacturer (Section D)
MEDCOMP
MDR Report Key18393557
MDR Text Key331325189
Report NumberMW5149532
Device Sequence Number1
Product Code MSD
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other
Type of Report Initial
Report Date 12/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/26/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Patient Sequence Number1
-
-